Safety and Effectiveness Study of the Reflection Ceramic Acetabular System

NCT00663351 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 456

Last updated 2022-10-13

Study results available
· View outcomes & findings →

Summary

This Post-Approval study is prospective follow-up study designed to evaluate the long-term safety and effectiveness of the Reflection Ceramic Acetabular System.

Conditions

Interventions

DEVICE

Reflection Ceramic-Ceramic Total Hip Replacement

Intervention: all patients in study required (intervention) a total hip replacement, and were randomized to receive either the (Study Device)Reflection Ceramic Acetabular System or the(Control Device) Reflection FSO V (5 hole)acetabular system. Both arms received either a Synergy porous coated or Spectron EF stem.

DEVICE

Reflection FSO V Total Hip Replacement

Intervention: all patients in study required (intervention) a total hip replacement, and were randomized to receive either the (Study Device)Reflection Ceramic Acetabular System or the(Control Device) Reflection FSO V (5 hole)acetabular system. Both arms received either a Synergy porous coated or Spectron EF stem.

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Scott Corpe, M.D. · Medical College of Georgia, Dept of Orthopaedic

  • Joseph Zuckerman, M.D. · Hospital of Joint Disease, Orthopaedic Institute

  • Jonathan P Garino, M.D. · Presbyterian Medical Center, Dept of Orthopaedic

  • Michael J Grecula, M.D. · University of Texas Medical Branch, Dept of Orthopaedic

  • James Howe, M.D. · University of Vermont

  • Michael Lynch, M.D. · The Memphis Orthopaedic Group, PC

  • Norman E Walter, M.D. · Family Orthopaedics

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Primary Completion
2014-10-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00663351 on ClinicalTrials.gov